ISRE Reporter-HEK293 Recombinant Cell Line (JAK pathway) from BPS Bioscience, Inc.

Supplier Images

ISRE Reporter-HEK293 Recombinant Cell Line (JAK pathway)

Dose Response of ISRE Reporter – HEK293 Cells to IFNα Inhibition of IFNα-induced Reporter Activity by JAK Inhibitor I in ISRE Reporter – HEK293 Cells
ISRE Reporter-HEK293 Recombinant Cell Line (JAK pathway)
ISRE Reporter-HEK293 Recombinant Cell Line (JAK pathway)
ISRE Reporter-HEK293 Recombinant Cell Line (JAK pathway)
ISRE Reporter-HEK293 Recombinant Cell Line (JAK pathway)

Be the first to write a review!

Supplier Page

Supplier Page from
BPS Bioscience, Inc. for
ISRE Reporter-HEK293 Recombinant Cell Line (JAK pathway)

Request Info

Description

The ISRE Reporter - HEK293 Cell Line is designed for monitoring the activity of the JAK/STAT signaling pathway. The ISRE Reporter - HEK293 Cell Line contains the firefly luciferase gene under the control of ISRE stably integrated into HEK293 cells

Product Specs
ItemISRE Reporter-HEK293 Recombinant Cell Line (JAK pathway)
CompanyBPS Bioscience, Inc.
Price $2,445.00Supplier Page View Company Product Page
Catalog Number60510
Quantity2 vials
TypeCell Line
Cell LineHEK293
ApplicationsMonitor IFNα-induced activity and the JAK/STAT pathway activity., Screen for activators or inhibitors of the JAK/STAT signaling pathway
Source/Expression SystemHEK293
human
Formataqueous solution containing DMSO
ActivityThis cell line is validated for the response to stimulation with interferon Alpha A and to treatment with JAK inhibitor